HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thor G Theander Selected Research

Plasmodium falciparum erythrocyte membrane protein 1

1/2019Associations between IgG reactivity to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens and Burkitt lymphoma in Ghana and Uganda case-control studies.
1/2019Acquisition of Antibodies Against Endothelial Protein C Receptor-Binding Domains of Plasmodium falciparum Erythrocyte Membrane Protein 1 in Children with Severe Malaria.
5/2016Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria.
11/2015Protein C system defects inflicted by the malaria parasite protein PfEMP1 can be overcome by a soluble EPCR variant.
8/2015IgG antibodies to endothelial protein C receptor-binding cysteine-rich interdomain region domains of Plasmodium falciparum erythrocyte membrane protein 1 are acquired early in life in individuals exposed to malaria.
2/2014DNA secondary structures are associated with recombination in major Plasmodium falciparum variable surface antigen gene families.
1/2013Plasmodium falciparum expressing domain cassette 5 type PfEMP1 (DC5-PfEMP1) bind PECAM1.
1/2013Expression of the domain cassette 8 Plasmodium falciparum erythrocyte membrane protein 1 is associated with cerebral malaria in Benin.
6/2012Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children.
11/2010Insect cells are superior to Escherichia coli in producing malaria proteins inducing IgG targeting PfEMP1 on infected erythrocytes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thor G Theander Research Topics

Disease

97Malaria
06/2022 - 04/2002
16Infections
12/2021 - 09/2002
14Falciparum Malaria (Plasmodium falciparum Malaria)
01/2021 - 06/2002
9Neoplasms (Cancer)
12/2021 - 10/2015
5Cerebral Malaria
03/2017 - 01/2013
2Circulating Neoplastic Cells
06/2022 - 01/2018
2Hypersensitivity (Allergy)
05/2022 - 04/2016
2Burkitt Lymphoma (Burkitt's Lymphoma)
01/2019 - 01/2017
2Noncommunicable Diseases
01/2018 - 04/2016
2Fever (Fevers)
06/2011 - 05/2003
1Skin Diseases (Skin Disease)
05/2022
1Allergic Contact Dermatitis
05/2022
1COVID-19
12/2021
1Birth Weight (Birth Weights)
11/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2021
1Human Influenza (Influenza)
07/2020
1Glioma (Gliomas)
01/2019
1Carcinoma (Carcinomatosis)
01/2018
1Parasitic Diseases (Parasitic Disease)
11/2016
1Neoplasm Metastasis (Metastasis)
10/2015
1Persistent Infection
01/2011
1Inflammation (Inflammations)
01/2010
1alpha-Thalassemia
05/2008
1Sickle Cell Trait
11/2007
1Anemia
05/2006
1Sickle Cell Anemia (Hemoglobin S Disease)
12/2005
1Glucosephosphate Dehydrogenase Deficiency
12/2005
1Inborn Genetic Diseases (Disease, Hereditary)
12/2005

Drug/Important Bio-Agent (IBA)

26AntibodiesIBA
01/2019 - 06/2002
24Proteins (Proteins, Gene)FDA Link
06/2022 - 09/2005
24AntigensIBA
07/2020 - 05/2002
23VaccinesIBA
05/2022 - 11/2002
18Immunoglobulin G (IgG)IBA
07/2020 - 08/2003
16Plasmodium falciparum erythrocyte membrane protein 1IBA
01/2019 - 05/2006
16Surface Antigens (Surface Antigen)IBA
01/2011 - 04/2002
14Chondroitin Sulfates (Chondroitin Sulfate)IBA
12/2021 - 07/2003
13Endothelial Protein C ReceptorIBA
03/2020 - 06/2013
5ChondroitinIBA
12/2021 - 07/2003
5Malaria VaccinesIBA
01/2017 - 11/2002
4Pharmaceutical PreparationsIBA
11/2021 - 11/2007
4EpitopesIBA
07/2020 - 11/2006
4Antimalarials (Antimalarial Agents)IBA
06/2011 - 05/2003
3GlycosaminoglycansIBA
12/2021 - 07/2003
3Proteoglycans (Proteoglycan)IBA
01/2019 - 10/2008
3LigandsIBA
07/2016 - 11/2010
3Lumefantrine Drug Combination Artemether (Coartem)FDA Link
12/2011 - 04/2009
3pyrimethamine drug combination fanasil (Fansidar)FDA Link
12/2011 - 05/2003
2Epithelial Cell Adhesion MoleculeIBA
06/2022 - 01/2018
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2017 - 01/2017
2Biomarkers (Surrogate Marker)IBA
07/2016 - 06/2007
2Cysteine (L-Cysteine)FDA Link
08/2015 - 05/2006
2Peptides (Polypeptides)IBA
01/2015 - 01/2013
2ImmunosorbentsIBA
11/2007 - 12/2006
2EnzymesIBA
11/2007 - 12/2006
2Immunoglobulins (Immunoglobulin)IBA
08/2005 - 11/2004
1AllergensIBA
05/2022
1AcetylgalactosamineIBA
12/2021
1Messenger RNA (mRNA)IBA
11/2021
1CarbohydratesIBA
01/2021
1Single-Chain AntibodiesIBA
01/2021
1Influenza Vaccines (Influenza Vaccine)FDA Link
07/2020
1Hemagglutinins (Hemagglutinin)IBA
07/2020
1Indicators and Reagents (Reagents)IBA
03/2020
1Aluminum Hydroxide (Algeldrate)FDA Link
10/2019
1LipidsIBA
10/2019
1EmulsionsIBA
10/2019
1saponin QA-21V1 (QS21)IBA
10/2019
1Tumor Biomarkers (Tumor Markers)IBA
01/2019
1Monoclonal AntibodiesIBA
01/2018
1Epidermal Growth Factor (EGF)IBA
01/2018
1CelluloseIBA
10/2017
1CytokinesIBA
10/2016
1ParaffinIBA
07/2016
1Formaldehyde (Formol)FDA Link
07/2016
1AutoantigensIBA
04/2016
1Protein CIBA
11/2015
1Diphtheria ToxinIBA
10/2015
1hemiasterlinIBA
10/2015
1Immunoglobulin FragmentsIBA
01/2014
1Blood Group Antigens (Blood Groups)IBA
11/2013
1Virulence Factors (Pathogenicity Factors)IBA
07/2013
1Membrane Proteins (Integral Membrane Proteins)IBA
02/2013
1Hemoglobins (Hemoglobin)IBA
01/2013
1Plasmodium falciparum VAR2CSA proteinIBA
07/2012
1Blocking AntibodiesIBA
09/2010
1InsecticidesIBA
07/2010
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
05/2010
1C-Reactive ProteinIBA
01/2010
1Immunoglobulin Gm AllotypesIBA
12/2009
1Immunoglobulin Km AllotypesIBA
12/2009
1adhesion receptorIBA
12/2009
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2008
1Fluorescent Dyes (Fluorescent Probes)IBA
06/2008
1Oligonucleotide ProbesIBA
11/2007
1TrypsinIBA
09/2007
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
12/2005

Therapy/Procedure

2Therapeutics
01/2018 - 11/2015
1Intramuscular Injections
10/2019
1Lasers (Laser)
06/2008
1Drug Therapy (Chemotherapy)
11/2007